HE4 tumor marker concentration in neoplastic peritoneal effusion and in peritoneal fluid associated with benign gynecological diseases

Table 2 HE4 concentrations in serum, peritoneal fluid and tumor/cyst fluid and CA125 concentrations in serum in examined groups

	HE4-peritoneal fluid [pmol/L]	HE4- serum [pmol/L]	CA125- serum [mIU/ml]	HE4 –tumor/cyst fluid [pmol/L]
Group I	3322	452.05	885.45	9162
[median/95% CI]	[10.78-6633.22]	[-272.37-1176.47]	[-732.04-2502.94]	[9157.69-9166.3]
Group II	2150	53.25	33.250	2694
[median/95% CI]	[-1334.88-5634.88]	[28.46-78.04]	[-8.01-74.51]	[-1902.9-7290.9]
p value	0.206376	0.0000001	0.0000001	-
Group I	3322	452.05	885.45	9162
[median/95% CI]	[10.78-6633.22]	[-272-1176.47]	[-732.04-2502.94]	[9157.69-9166.3]
Group III	627.4	87.6	231.6	10522
[median/95% CI]	[-132.1-1386.9]	[17.63-157.57]	[-191.76-654.96]	-
p value	0.05929	0.001652	0.010584	-
Group II	2150	53.25	33.250	2694
[median/95% CI]	[-1334.88-5634.88]	[28.46-78.04]	[-8.01-74.51]	[-1902.9-7290.9]
Group III	627.4	87.6	231.6	10522
[median/95% CI]	[-132.1-1386.9]	[17.63-157.57]	[-191.76-654.96]	-
p value	0.0797	0.003943	0.043166	-

ISSN: 1757-2215